Skip to main content

Mitsui Increases Stake In API Maker - Arch Pharmalabs


Japanese diversified trading company - Mitsui has acquired 25% stake in API maker Arch Pharmalabs for R372 Cr increasing its stake to 30%, according to ET.
Mitsui is buying out the stakes of IL&FS Trust Co, IDBI Trusteeship Services and Rainbow Fund. The move will lead to exit for these funds.
The deal will also increase the stake of foreign investors in the Indian company to 46%. Other investor includes – ICICI Venture, Dynamic India Fund, Granite Hill India Oppourtunities Fund and Leverage India Fund among others.
Incorporated in 1993, Arch Pharmalabs as Merven Drug is engaged in the manufacturing of API / intermediates and also offers CRAMS. APL has 11 multipurpose manufacturing facilities (including two facilities owned by its subsidiary Avon Organics Limited) across Maharashtra (Six), Andhra Pradesh (Four) and Gurgaon. Out of these facilities, three are USFDA approved (including one owned by Avon Organics Limited) and one of the USFDA unit has also been approved by EDQM, TGA-Australia and PMDA-Japan. 
The company also has its Corporate R&D center located at Taloja. As on March 31, 2011, APL had four subsidiaries and one step-down subsidiary, out of which only Avon Organics is operational. 
Last year, Arch had planned for an IPO to raise around R135 Cr, but didn’t go forward with the plan due to adverse IPO market condition.
Mitsui & Co is a diversified conglomerate with interests across trading, investment and service enterprise. It is also engaged in product sales, logistics and financing. Mitsui also has a significant stake in an API company in Japan and a formulations facility in China.
In 2010, Mitsui & Co acquired 5% stake in Arch Pharmalabs for around R65 Cr.
In 2011, it also invested $12Mn in IFC backed Suvidhaa Infoserve for a minority stake.
Similar transaction in the space includes - Bilcare Limited signed an agreement with United Drug Plc. for the sale of its Global Clinical Supplies (GCS) businesses in the U.S and U.K.; Japanese drug maker Takeda infused around $5 Mn in Advinus Therapeutics; B Braun Singapore Pte is acquiring 26% in New Delhi based Ahlcon Parenterals (India) Ltd through an open offer and many more.'


Sandip Ginodia
ABHISHEK SECURITIES

We deal in over 60 unlisted companies with 15 years of expeirence . For latest prices visit :www.abhisheksecurities.com/unlisted.htm / call : 09830271248 .



For more info and regular updates about unlisted shares and the stock market :

Like us on facebook : www.facebook.com/abhisheksecurities 
Labels:

Comments

Post a Comment

Please leave your name and email id along with the comment .
Get the updates from this blog direct to your inbox . Fill in your email id on the home page.

Popular posts from this blog

Reliance's JioMart is averaging half a million orders per day; WhatsApp driving growth

  JioMart , Reliance's online-to-offline commerce  platform that launched in May , has scaled up rapidly, riding on the pandemic-fuelled digital acceleration. The service, which went   live in 200 cities across India, is currently processing an average of  500,000 orders per day. " We can go even higher on peak days",  Jio Platforms CEO   Kiran Thomas  revealed at the Facebook for Fuel India 2020 event. He said, "JioMart is empowering millions of  kiranas  and small merchants through the simple and secure platform of WhatsApp, and linking them to Reliance Retail's pan-India supply chain. We expect to grow manifold in future, and are optimistic about enabling new cohorts of users and making it easier for them to shop for daily essentials."  "Customers are transacting seamlessly on JioMart and the  conversational nature of the service  enabled by WhatsApp has made people adapt to it intuitively," he added. Reliance also stated that it will continue t
Post a Comment
Read more

Stock broker SMC Global files for IPO

F inancial services company SMC Global Securities has filed draft red herring prospectus with SEBI for public issue of 1,58,67,380 equity shares of face value of Rs 2 each. The issue comprises a fresh issue of 79,33,690 equity shares by the company and an offer for sale of 79,33,690 shares by Millennium India Acquisition Company Inc. As of September 30, 2012, "We service our broking clients through a network of 43 branches and 2,521 registered sub-brokers and authorized persons spread in more than 500 cities and towns. We have also established an office in Dubai for brokerage and trading activities in that region," the company said. SMC has reported a loss of Rs 0.42 crore and total revenues of Rs 292.24 crore in the year ended March 31, 2012. "The proceeds of the fresh issue shall be utilised for margin maintenance with stock exchanges; part repayment of term loan; investments into subsidiary, SMC Comtrade; and general corporate purposes," according to p
10 comments
Read more

TCS merger with TCS e serve

The board of Tata Consultancy Services (TCS) in its meeting on 18 October 2012 has approved the composite scheme of arrangement between TCS, TCS e-Serve (e-Serve) and TCS e-Serve International (TEIL). The composite scheme of arrangement provides for merger of e-Serve into TCS and demerger of TEIL's special economic zone (SEZ) undertaking(s) to TCS. The appointed date proposed for this scheme is 01 April 2013. TCS holds 96.26% of the paid up equity share capital of e-Serve. TEIL is a wholly owned subsidiary of e-Serve. As per the terms of the scheme of arrangement, shareholders of e-Serve (other than TCS) will receive 13 equity shares of Re 1 each of TCS for every 4 equity shares of Rs 10 each of e-Serve held by them. The board has approved the scheme of merger of Computational Research Laboratories (CRL) and Retail FullServe (RFL) with TCS. The proposed appointed date for the merger of CRL is 01 October 2012 and for the merger of RFL is 01 April 2012. Computational Res
2 comments
Read more